HYPERRAB
GRIFOLS THERAPEUTICS LLC
Quick answers
Is there a shortage of HYPERRAB in Canada?
No. There is no current shortage of HYPERRAB 300UNIT reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
IMOGAM RABIES INJ 150UNIT/ML
PASTEUR MÉRIEUX SERUMS ET VACCINS, S.A.
HYPERAB RABIES IMMUNE GLOBULIN HUMAN
CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD.
IMOGAM RABIES PASTEURIZED
SANOFI VACCINES CANADA LTD.
HYPERRAB S/D
GRIFOLS THERAPEUTICS LLC
DIN
02486571
Strength
300UNIT
Dosage Form
Solution
Route
Intramuscular
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from GRIFOLS THERAPEUTICS LLC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
25% · DIN 02223708
5% · DIN 02223694
18% · DIN 02486598
10G · DIN 02247724
110UNIT · DIN 02520125
220UNIT · DIN 02520001
250UNIT · DIN 02520087
10G · DIN 02277921
50MG · DIN 02189100
1000MG · DIN 02204606